or Try an Advanced Search...

    Treatment Of Hemophilia Stocks List

    Symbol Grade Name % Change
    CNTA B Centessa Pharmaceuticals plc -8.57
    QURE C uniQure N.V. -8.07
    ALNY D Alnylam Pharmaceuticals, Inc. -8.67
    BIIB F Biogen Idec Inc. -2.97
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hemophilia Acute Intermittent Porphyria Biopharmaceutical Biotechnology Clinical Development Deficiency Hemophilia A Idiopathic Pulmonary Fibrosis Lupus Spinal Muscular Atrophy Adeno Associated Virus Alipogene Tiparvovec Alnylam Pharmaceuticals Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency Alzheimer's Disease Amyloid Amyloidosis Antitrypsin Deficiency Applied Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hemophilia stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 9.15
    MNTL F Tema Neuroscience and Mental Health ETF 8.09
    BIS B ProShares UltraShort Nasdaq Biotechnology 8.07
    MEDX F Horizon Kinetics Medical ETF 7.68
    BBH D Market Vectors Biotech ETF 7.44
    View all Treatment Of Hemophilia ETFs...
    Compare ETFs
    Compare BIS to MEDX Compare PBE to BIS Compare PBE to MEDX

        Treatment Of Hemophilia Stocks Recent News

        Date Stock Title
        Nov 15 BIIB Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
        Nov 14 BIIB European committee takes a second look at Alzheimer's drug and now says it should be approved
        Nov 14 BIIB 5 Healthcare Stocks to Buy in a Beaten-Up Sector
        Nov 14 BIIB Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
        Nov 14 BIIB Biogen gains as Eisai wins EU nod for Alzheimer’s drug
        Nov 14 BIIB Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal
        Nov 14 BIIB Peeling Back The Layers: Exploring Biogen Through Analyst Insights
        Nov 14 BIIB Citi initiates coverage on 5 new biotech stocks
        Nov 14 BIIB RNA Stock Hits Record High on Entering the Cardiac Disease Space
        Nov 13 BIIB Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
        Nov 13 CNTA Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
        Nov 12 BIIB Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View
        Nov 12 ALNY Alnylam downgraded at Wolfe on doubts over Amvuttra growth
        Nov 12 CNTA Centessa Pharmaceuticals GAAP EPS of -$0.37
        Nov 12 CNTA Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
        Nov 12 ALNY 3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hemophilia Acute Intermittent Porphyria Biopharmaceutical Biotechnology Clinical Development Deficiency Hemophilia A Idiopathic Pulmonary Fibrosis Lupus Spinal Muscular Atrophy Adeno Associated Virus Alipogene Tiparvovec Alnylam Pharmaceuticals Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency Alzheimer's Disease Amyloid Amyloidosis Antitrypsin Deficiency Applied Genetics
        Treatment Of Hemophilia

        Treatment of hemophilia typically involves the use of replacement therapy, which involves infusions of clotting factor concentrates. These concentrates are made from donated human plasma and are designed to replace the missing clotting factor in the blood. Other treatments may include physical therapy, medications to reduce pain and swelling, and surgery to repair damaged joints.

        Browse All Tags